Correlations between in vivo 1H MRS and ex vivo 1H HRMAS metabolite measurements in adult human gliomas

To assess how accurately ex vivo high‐resolution magic angle spinning (HRMAS) proton magnetic resonance spectroscopy (1H MRS) from small biopsy tissues relate to in vivo 1H MRS (from larger tumor volumes) in human astrocytomas.

[1]  Tanja Woyke,et al.  Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets. , 2005, Neoplasia.

[2]  David G. Gadian,et al.  Proton MR Spectroscopy of Intracranial Tumours: In Vivo and In Vitro Studies , 1990, Journal of computer assisted tomography.

[3]  R. Sauter,et al.  Intratumoral lipids in 1H MRS in vivo in brain tumors: experience of the Siemens cooperative clinical trial. , 1996, Anticancer research.

[4]  A Moreno,et al.  Evidence that mobile lipids detected in rat brain glioma by 1H nuclear magnetic resonance correspond to lipid droplets. , 1997, Cancer research.

[5]  Mathias Hoehn,et al.  Metabolic differences between primary and recurrent human brain tumors: a 1H NMR spectroscopic investigation , 2005, NMR in biomedicine.

[6]  L. Astrakas,et al.  Combination of high-resolution magic angle spinning proton magnetic resonance spectroscopy and microscale genomics to type brain tumor biopsies. , 2007, International journal of molecular medicine.

[7]  Y. Kinoshita,et al.  Absolute concentrations of metabolites in human brain tumors using in vitro proton magnetic resonance spectroscopy , 1997, NMR in biomedicine.

[8]  T. Bathen,et al.  Metabolic mapping by use of high-resolution magic angle spinning 1H MR spectroscopy for assessment of apoptosis in cervical carcinomas , 2007, BMC Cancer.

[9]  Ying Lu,et al.  Identification of MRI and 1H MRSI parameters that may predict survival for patients with malignant gliomas , 2004, NMR in biomedicine.

[10]  D Guerrero.  BRAIN TUMOURS , 1999, Nursing times.

[11]  M. Papadopoulos,et al.  Survival of patients with glioblastoma multiforme has not improved between 1993 and 2004: analysis of 625 cases , 2007, British journal of neurosurgery.

[12]  J. Walecki,et al.  1H-MRS in vivo predicts the early treatment outcome of postoperative radiotherapy for malignant gliomas. , 2002, International journal of radiation oncology, biology, physics.

[13]  V. L. Doyle,et al.  Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy , 2003, Magnetic resonance in medicine.

[14]  S. Kalra,et al.  Measurement of glycine in human brain by triple refocusing 1H‐MRS in vivo at 3.0T , 2008, Magnetic resonance in medicine.

[15]  F. Howe,et al.  An assessment of the effects of sample ischaemia and spinning time on the metabolic profile of brain tumour biopsy specimens as determined by high‐resolution magic angle spinning 1H NMR , 2008, NMR in biomedicine.

[16]  D R Rutgers,et al.  Relaxation times of choline, creatine and N‐acetyl aspartate in human cerebral white matter at 1.5 T , 2002, NMR in biomedicine.

[17]  S. Holm.  A Simple Sequentially Rejective Multiple Test Procedure , 1979 .

[18]  M. Décorps,et al.  Correlation between the occurrence of 1H‐MRS lipid signal, necrosis and lipid droplets during C6 rat glioma development , 2003, NMR in biomedicine.

[19]  F. Howe,et al.  Differentiation of metastases from high‐grade gliomas using short echo time 1H spectroscopy , 2004, Journal of magnetic resonance imaging : JMRI.

[20]  Leo L. Cheng,et al.  Proton high‐resolution magic angle spinning NMR analysis of fresh and previously frozen tissue of human prostate , 2003, Magnetic resonance in medicine.

[21]  Napapon Sailasuta,et al.  A comparative study of myo-inositol quantification using LCmodel at 1.5 T and 3.0 T with 3 D 1H proton spectroscopic imaging of the human brain. , 2004, Magnetic resonance imaging.

[22]  M. Dossena,et al.  Relationships between γ‐aminobutyrate and succinate cycles during and after cerebral ischemia , 1982 .

[23]  Tchoyoson C. C. Lim,et al.  Targeting regions with highest lipid content on MR spectroscopy may improve diagnostic yield in stereotactic biopsy , 2008, Journal of Clinical Neuroscience.

[24]  F. Howe,et al.  Toward accurate quantification of metabolites, lipids, and macromolecules in HRMAS spectra of human brain tumor biopsies using LCModel , 2008, Magnetic resonance in medicine.

[25]  V. Govindaraju,et al.  Proton NMR chemical shifts and coupling constants for brain metabolites , 2000, NMR in biomedicine.

[26]  J. Alger,et al.  High‐Resolution Proton Magnetic Resonance Spectroscopy of Rabbit Brain: Regional Metabolite Levels and Postmortem Changes , 1988, Journal of neurochemistry.

[27]  R. Shank,et al.  Post mortem changes in the content and specific radioactivity of several amino acids in four areas of the rat brain. , 1971, Journal of neurobiology.

[28]  G Friedmann,et al.  Human brain tumors: spectral patterns detected with localized H-1 MR spectroscopy. , 1992, Radiology.

[29]  Martin Wilson,et al.  A quantitative comparison of metabolite signals as detected by in vivo MRS with ex vivo 1H HR‐MAS for childhood brain tumours , 2009, NMR in biomedicine.

[30]  M. Berens,et al.  Molecular targets of glioma invasion , 2007, Cellular and Molecular Life Sciences.

[31]  Franklyn A Howe,et al.  An investigation of human brain tumour lipids by high‐resolution magic angle spinning 1H MRS and histological analysis , 2008, NMR in biomedicine.

[32]  T. Perry,et al.  Postmortem Changes of Amino Compounds in Human and Rat Brain , 1981, Journal of neurochemistry.

[33]  M. Leach,et al.  Could assessment of glioma methylene lipid resonance by in vivo (1)H-MRS be of clinical value? , 2003, The British journal of radiology.

[34]  J R Griffiths,et al.  Linear discriminant analysis of brain tumour 1H MR spectra: a comparison of classification using whole spectra versus metabolite quantification , 2007, NMR in biomedicine.

[35]  R. Kauppinen,et al.  Choline‐Containing Compounds in Human Astrocytomas Studied by 1H NMR Spectroscopy In Vivo and In Vitro , 1994, Journal of neurochemistry.

[36]  S. Provencher.  Estimation of metabolite concentrations from localized in vivo proton NMR spectra , 1993, Magnetic resonance in medicine.

[37]  F. Thorsen,et al.  Brain tumor cell invasion, anatomical and biological considerations. , 1997, Anticancer research.

[38]  J. Mcculloch,et al.  Proteomic analysis of gliomas , 2007, British journal of neurosurgery.

[39]  P. Carroll,et al.  Quantitative analysis of prostate metabolites using 1H HR‐MAS spectroscopy , 2006, Magnetic resonance in medicine.

[40]  T. Mcknight,et al.  Proton magnetic resonance spectroscopic evaluation of brain tumor metabolism. , 2004, Seminars in oncology.

[41]  R. Gonzalez,et al.  Correlation of high-resolution magic angle spinning proton magnetic resonance spectroscopy with histopathology of intact human brain tumor specimens. , 1998, Cancer research.

[42]  J. Frahm,et al.  Metabolic Alterations in Brain Autopsies: Proton NMR Identification of Free Glycerol , 1996, NMR in biomedicine.

[43]  F. Howe,et al.  Apparent T2 relaxation times of lipid and macromolecules: A study of high‐grade tumor spectra , 2008, Journal of magnetic resonance imaging : JMRI.

[44]  P G Webb,et al.  Automated single‐voxel proton MRS: Technical development and multisite verification , 1994, Magnetic resonance in medicine.